Literature DB >> 15996480

Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans.

Daniela Frasca1, Richard L Riley, Bonnie B Blomberg.   

Abstract

Vaccinations are powerful tools for combating infections. Because of the age-related impairment in immune functions, the currently available vaccines are protecting only a small proportion of the elderly population. We, here, provide an overview of age-related changes in innate and adaptive immunity with particular emphasis to changes in antibody production with aging. We also summarize our results showing that the E2A-encoded transcription factor E47, which regulates many B cell functions including class switch recombination (CSR) and somatic hypermutation (SHM), is downregulated in splenic B cells from old mice. This leads to a reduction in the activation-induced cytidine deaminase (AID), which directly induces CSR and SHM, and, in turn, to reduced amounts of switched antibodies produced by splenic activated B cells. Our preliminary results in humans indicate similar reductions: we show herein that the expression of E2A and AID progressively decline with age. Our results provide a possible molecular basis for a decrease in the humoral immune response in aging mice and humans.

Entities:  

Mesh:

Year:  2005        PMID: 15996480     DOI: 10.1016/j.smim.2005.05.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  48 in total

1.  Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity.

Authors:  Sue Stacy; Earlanda L Williams; Nathan E Standifer; Amanda Pasquali; Keith A Krolick; Anthony J Infante; Ellen Kraig
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 2.  Aging of the immune system: how much can the adaptive immune system adapt?

Authors:  Nan-Ping Weng
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

3.  B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins.

Authors:  Jannek Hauser; Natalia Sveshnikova; Anders Wallenius; Sanna Baradaran; Juha Saarikettu; Thomas Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-18       Impact factor: 11.205

Review 4.  Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity.

Authors:  Midas Seyda; Markus Quante; Hirofumi Uehara; Bendix R Slegtenhorst; Abdala Elkhal; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

5.  Perspective on potential clinical applications of recombinant human interleukin-7.

Authors:  Claude Sportès; Ronald E Gress; Crystal L Mackall
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

Review 6.  Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?

Authors:  Raymond Chuen-Chung Chang; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

7.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 8.  Immunological outcomes of exercise in older adults.

Authors:  David S Senchina; Marian L Kohut
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.